Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatic Mitral Stenosis.

Feldman1

  • 1Cardiac Catheterization Laboratory, University of Chicago Hospital, 5841 S. Maryland Ave., MC 5076, Chicago, IL 60637, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Outpatient vitreoretinal surgery without next-day examination: Feasibility and acceptability].

Journal francais d'ophtalmologie·2018
Same author

General account of the criteria for treating wounds on the European front.

La Semana medica·2010
Same author

Comment I on "Simple measure for complexity"

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Same author

Elastic compton scattering from the deuteron and nucleon polarizabilities

Physical review letters·2000
Same author

Quasi-long-range order in nematics confined in random porous media

Physical review letters·2000
Same author

Quasifree compton scattering from the deuteron and nucleon polarizabilities

Physical review letters·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Percutaneous transvenous mitral commissurotomy (PTMC) is recommended for symptomatic mitral stenosis patients with suitable valve morphology, offering outcomes comparable to surgery. Valve replacement is for severe deformities, while PTMC can be a palliative option for high-risk older patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Echocardiography

Background:

  • Mitral stenosis is a significant valvular heart disease.
  • Current treatment guidelines emphasize echocardiography for evaluation.
  • Percutaneous transvenous mitral commissurotomy (PTMC) is a key therapeutic option.

Purpose of the Study:

  • To outline the management strategy for symptomatic and asymptomatic mitral stenosis.
  • To define patient selection criteria for percutaneous transvenous mitral commissurotomy (PTMC).
  • To compare PTMC with surgical commissurotomy and mitral valve replacement.

Main Methods:

  • Transthoracic and transesophageal echocardiography for patient evaluation.
  • Percutaneous transvenous mitral commissurotomy (PTMC) for suitable candidates.

Related Experiment Videos

  • Review of randomized trials comparing catheter and surgical commissurotomy.
  • Assessment of mitral valve replacement for severe deformities.

    • Main Results:

    • PTMC shows no long-term outcome difference compared to surgical commissurotomy in suitable patients.
    • Surgical commissurotomy has no role when balloon commissurotomy is feasible.
    • Mitral valve replacement is indicated for severe valve deformities.
    • PTMC can be a palliative option for high-risk older patients.

    Conclusions:

    • PTMC is the preferred treatment for suitable mitral stenosis patients.
    • Echocardiography is crucial for guiding treatment decisions.
    • Asymptomatic patients with pulmonary hypertension may benefit from PTMC.